评价药学干预在2型糖尿病多药联合治疗中的作用

Effect Evaluation of Pharmaceutical Intervention on Multidrug Combination Therapy for Type 2 Diabetes

目的评价药学干预在2型糖尿病(T2DM)多药联合治疗中发挥的作用。方法研究时间以2017年1月至12月为准,以120例T2DM患者为例,根据随机双盲法分组,两组均接受多药联合治疗,观察组在此基础上给予药物干预,对照组不实施干预。对比两组患者用药依从性、血糖控制率及不良反应情况。结果与对照组比较,观察组患者用药依从率95.00%、血糖控制率90.00%、不良反应发生率8.34%均更加理想,P<0.05。结论药学干预的实施能保证多药联合治疗的2型糖尿病患者治疗效果,同时对于提高患者用药依从性,减少用药不良反应有积极意义。

Objective to evaluate effect of pharmaceutical intervention on multi-drug combination therapy for type 2 diabetes mellitus(T2DM).Methods divide 120 cases type 2 diabetes patients into two groups from Jan to Dec,2017 according to random double-blind method.Both groups received multi-drug combination therapy.Observation group was treated with drug intervention on above basis.Control group was not treated with intervention.Compare drug compliance,blood sugar control rate and adverse reactions between two groups.Results compared with control group,compliance rate of observation group was 95.00%,control rate of blood sugar was 90.00%,and incidence of adverse reactions was 8.34%,which were more ideal,P<0.05.Conclusion implementation of pharmaceutical intervention can ensure curative effect of multi-drug combination therapy for type 2 diabetes,at the same time,it has positive significance for improving drug compliance of patients and reducing adverse drug reactions.